Hot Investor Mandate 4: Multi-Stage VC Invests in Biotech With A Focus on Europe

13 Apr

A multi-stage venture capital firm in Europe invests in life science companies with a focus on niche indications with verified technology. The firm can allocate up to €10-15M per company and typically provides equity as well as debt financing. The firm generally acts as the lead or co-lead investor and is open to invest in syndicates. Currently, the firm seeks to invest in companies that are based in the European Union or US company that is open for an EU entity. The firm is actively seeking new investment opportunities.

The firm is currently seeking to invest in innovative biotech therapeutics and pharmaceuticals with clear biology and verified technology. The firm is also interested in exceptional medical devices with a therapeutic application that is close to market or has generated some sales. The firm is opportunistic across the therapeutic subsectors but prefers products that target niche indications. Currently, the firm is more interested in oncology and orphan indications.

The firm requests a board seat in each portfolio company. The firm seeks a strong and experienced management team.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: